This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acne Vulgaris
and you are
between 18 and 35
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The aim of this proof of principle study is to evaluate efficacy and safety of the sequential application of two marketed products for the treatment of acne vulgaris, using the Split-Face model

Provided treatments

  • Drug: marketed topical retinoid
  • Drug: marketed topical NSAID
  • Drug: vehicle gel
  • Drug: marketed topical retinoid

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01461655. The sponsor of the trial is LEO Pharma and it is looking for 40 volunteers for the current phase.
Official trial title:
Exploratory Study Evaluating the Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris, Using a Split-Face Model